FDA product code CKH: Acid Phosphatase, Beta Glycerophosphate
CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel. Devices under CKH reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for CKH devices.
Classification
| Field | Value |
|---|---|
| Device name | Acid Phosphatase, Beta Glycerophosphate |
| Device class | Class II |
| Regulation | 21 CFR 862.1020 |
| Review panel | CH — Clinical Chemistry |
| Medical specialty | Clinical Chemistry |
| Premarket route | 510(k) exempt |
Recalls for CKH devices
1 product recalls in 1 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2004-08-20.
Frequently asked questions
What is FDA product code CKH?
CKH is the FDA product code for acid phosphatase, beta glycerophosphate. It is a Class II device, regulated under 21 CFR 862.1020 and reviewed by the Clinical Chemistry panel.
What device class is CKH?
Class II, regulation 21 CFR 862.1020. Typical premarket route: 510(k) exempt.
Have CKH devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2004-08-20.
Next steps
- Run an FDA pathway report with predicate devices for product code CKH
- Run a recall and safety report across every CKH manufacturer
- Watch product code CKH for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times